EMA Broadens Imvanex Vaccine Use to Teens as Mpox Cases Rise ...Middle East

Medscape - News
With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years. Medscape Medical News

Hence then, the article about ema broadens imvanex vaccine use to teens as mpox cases rise was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( EMA Broadens Imvanex Vaccine Use to Teens as Mpox Cases Rise )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News